why choose us

First received: February 08, 2026

Clinical Trial: Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pneumonia

Study Type: OBSERVATIONAL


Official Title: Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Brief Summary: This is a single-center, non-profit observational study with two sequential phases: an initial retrospective phase followed by a prospective phase.Patients were enrolled during two consecutive, non-overlapping periods.The primary objective of the study is to derive a clinical predictive score for multidrug-resistant (MDR) pathogen-related pneumonia in patients diagnosed with pneumonia presenting to the Emergency Department and/or admitted to the hospital from the community.

Read more